Oral health/diabetes campaign
This article was originally published in The Tan Sheet
Colgate-Palmolive partners with the American Diabetes Association to educate medical professionals and diabetes patients about the link between oral health and diabetes, the firm announces April 14. Emerging research suggests "not only are people with diabetes more susceptible to periodontal disease, but the presence of gum disease may have the potential to affect blood glucose control and contribute to the progression of diabetes," Colgate says. The multi-year educational campaign will include a new oral care section on ADA's Web site as well as "Ask the Dentist" - an online chat series, "Interactive Oral Hygiene" - an oral health quiz and patient education materials. Colgate and ADA also will conduct a joint symposium for health care professionals on diabetes and periodontal disease at the 2008 American Diabetes Association Scientific Sessions, the firm says...
You may also be interested in...
Medtech Insight spoke to attorney Greg Dadika about mass tort litigation, including industry trends, how to find the right law firm, and when it’s the right time to settle a suit. See what Dadika, an attorney at the law firm Greenberg Traurig LLP, said about it here.
Sotagliflozin Hail Mary? Lexicon Seeks Opportunity For Formal Hearing On FDA Intent To Deny Approval
After complete response letter, Lexicon triggers rarely used mechanism for formal hearing, prompting US FDA to publicly list its problems with the proposed type 1 diabetes drug, for which Sanofi had originally sought approval.
AstraZeneca/FibroGen’s Roxadustat Comparison To ESAs In Anemia May By Clarified At FDA Advisory Cmte.
Payers would welcome any additional clarity provided by advisory panel review, given the perception, expressed in a recent ICER report, that the evidence is insufficient to determine whether the new drug is safer or more effective than erythropoiesis-stimulating agents.